You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,021,344


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,021,344
Title:Medicament delivery device configured to produce an audible output
Abstract: Medicament delivery devices are described herein. In some embodiments, an apparatus includes a medicament delivery device and an electronic circuit system. The medicament delivery device includes a housing, a medicament container, and a medicament delivery member. The electronic circuit system is coupled to the housing and includes an audible output device and a cover. The housing of the medicament delivery device and the cover of the electronic circuit system collectively define an acoustic enclosure. The audible output device is configured to be disposed within the acoustic enclosure.
Inventor(s): Edwards; Eric S. (Midlothian, VA), Edwards; Evan T. (Gordonsville, VA), Licata; Mark J. (Doswell, VA), Meyers; Paul F. (Fishers, IN), Weinzierl; David A. (Andover, MN)
Assignee: Intelliject, Inc. (Richmond, VA)
Application Number:12/180,708
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;
Patent landscape, scope, and claims:

United States Patent 8,021,344: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 8,021,344, titled "Medicament delivery device configured to produce an audible output," is a significant innovation in the field of medical devices. This patent, granted to various inventors and assignees, highlights the importance of precise claim drafting, patent scope, and the broader patent landscape.

Background of the Patent

The patent US 8,021,344 was granted for a medicament delivery device designed to produce an audible output, indicating the successful administration of a medication. This device is crucial for ensuring patient compliance and safety, especially in scenarios where visual feedback may not be sufficient or reliable[4].

Patent Claims

Independent and Dependent Claims

The patent includes a set of independent and dependent claims that define the scope of the invention. Independent claims are standalone and do not rely on other claims, while dependent claims build upon the independent claims to provide additional details or limitations.

  • Independent Claims: These claims define the core aspects of the medicament delivery device, including the mechanism for producing an audible output. For example, Claim 1 might describe the device as a whole, while subsequent independent claims might focus on specific components or functionalities.
  • Dependent Claims: These claims further specify the invention by adding additional features or limitations to the independent claims. For instance, a dependent claim might describe the type of audible output or the method of producing it.

Claim Language and Scope

The language used in patent claims is critical for defining the patent's scope. The scope determines what is protected under the patent and what is not. In the case of US 8,021,344, the claims must clearly describe the device's functionality and the audible output mechanism to avoid ambiguity and ensure enforceability.

Metrics for Measuring Patent Scope

Research on patent scope often employs metrics such as independent claim length and independent claim count to assess the breadth and clarity of patent claims. These metrics can indicate the complexity and specificity of the invention:

  • Independent Claim Length: Longer independent claims may indicate a more detailed and specific description of the invention, potentially narrowing the patent scope.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, as it covers more aspects of the invention[3].

Patent Examination Process

The examination process for US 8,021,344 would have involved several stages, including initial filing, review, and potential amendments. The USPTO examines patent applications to ensure that the claims are clear, novel, and non-obvious.

  • Narrowing Claims: During the examination process, claims may be narrowed to address examiner objections or to differentiate the invention from prior art. This narrowing can affect the patent's scope and validity[3].

Case Studies on Patent Claims and Scope

Synchronoss Technologies, Inc. v. DropBox, Inc.

A notable case highlighting the importance of precise claim language is Synchronoss Technologies, Inc. v. DropBox, Inc. Here, the patent was invalidated due to contradictions in the claim language, which made the claims "impossible" and "nonsensical." This case underscores the need for careful review and consistency in claim drafting to avoid such outcomes[5].

Patent Landscape

Related Patents and Prior Art

The patent landscape for medicament delivery devices includes a variety of related patents and prior art. For example, patents like US 9,566,395 B2, which describes a medicament storage, dispensing, and administration system, show the evolving nature of medical device technology[1].

  • Prior Art: The existence of prior art can influence the scope and validity of a patent. In the case of US 8,021,344, the inventors would have needed to demonstrate how their device differs from existing technologies.

Economic and Legal Implications

Patents like US 8,021,344 have significant economic and legal implications. They can impact the market by providing exclusive rights to the inventors, influencing competition, and driving innovation.

  • Licensing and Litigation: The clarity and scope of patent claims can affect licensing agreements and litigation outcomes. Clear and well-defined claims reduce the likelihood of disputes and enhance the patent's value[3].

Data and Statistics

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides insights into patent claims and their characteristics. This dataset can be used to analyze trends in patent scope and claim language over time. For instance, it shows that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[2].

Practical Lessons for Inventors and Patent Counsel

The analysis of US 8,021,344 and related cases offers several practical lessons:

  • Careful Claim Drafting: Ensure that claim language is clear, consistent, and free of contradictions.
  • Review and Amendments: Regularly review and amend claims during the prosecution process to maintain clarity and validity.
  • Understanding Patent Scope: Use metrics such as independent claim length and count to assess and manage the patent's scope effectively[3][5].

Key Takeaways

  • Clear Claim Language: Precise and consistent claim language is crucial for the validity and enforceability of a patent.
  • Patent Scope Metrics: Metrics like independent claim length and count can help in assessing the breadth and clarity of patent claims.
  • Examination Process: The patent examination process can significantly impact the scope and validity of a patent.
  • Economic and Legal Implications: Patents have substantial economic and legal implications, influencing market competition and innovation.

FAQs

Q: What is the significance of the audible output in the medicament delivery device described in US 8,021,344?

A: The audible output is significant as it provides feedback to the user, ensuring that the medication has been successfully administered, which is particularly important for patient compliance and safety.

Q: How do independent claim length and count affect the patent scope?

A: Independent claim length and count are metrics used to measure patent scope. Longer independent claims and fewer claims generally indicate a narrower scope, while shorter claims and more claims can suggest a broader scope.

Q: What happened in the Synchronoss Technologies, Inc. v. DropBox, Inc. case?

A: The patent was invalidated due to contradictions in the claim language, which made the claims "impossible" and "nonsensical," highlighting the importance of careful claim drafting.

Q: How does the USPTO's Patent Claims Research Dataset help in analyzing patent claims?

A: The dataset provides detailed information on claims from US patents, allowing for the analysis of trends in patent scope and claim language over time.

Q: What are the practical lessons for inventors and patent counsel from the analysis of US 8,021,344?

A: Inventors and patent counsel should ensure careful claim drafting, regularly review and amend claims, and understand the metrics for assessing patent scope to maintain clarity and validity.

Sources

  1. United States Patent and Trademark Office, US9566395 B2, February 14, 2017.
  2. United States Patent and Trademark Office, Patent Claims Research Dataset, August 28, 2017.
  3. SSRN, Patent Claims and Patent Scope, September 29, 2016.
  4. PubChem, US8021344, Accessed December 20, 2024.
  5. Wyatt Firm, Patent Invalidated Due To “Impossibility” In The Claims, April 6, 2021.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,021,344

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-003 Nov 17, 2017 RX Yes No 8,021,344 ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-002 Aug 10, 2012 BX RX Yes Yes 8,021,344 ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-001 Aug 10, 2012 BX RX Yes No 8,021,344 ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc EVZIO naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 205787-001 Apr 3, 2014 DISCN Yes No 8,021,344 ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc EVZIO (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 209862-001 Oct 19, 2016 DISCN Yes No 8,021,344 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,021,344

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004325202 ⤷  Subscribe
Australia 2006210865 ⤷  Subscribe
Australia 2007245139 ⤷  Subscribe
Australia 2009200841 ⤷  Subscribe
Australia 2009246525 ⤷  Subscribe
Australia 2012201481 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.